Jessyca Aparecida Paes Dutra

Ms. Jessyca Aparecida Paes Dutra

São Paulo State University, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MLMarcela Tavares Luiz
Marcela Tavares Luiz
JDJessyca Aparecida Paes Dutra
Jessyca Aparecida Paes Dutra
LTLarissa Bueno Tofani
Larissa Bueno Tofani
JAJennifer Thayanne Cavalcante De Araújo
Jennifer Thayanne Cavalcante De Araújo
LFLeonardo Delello Di Filippo
Leonardo Delello Di Filippo
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Cancer is the second most frequent cause of death worldwide, with 28.4 million new cases expected for 2040. Despite de advances in the treatment, it remains a challenge because of the tumor heterogenicity and the increase in multidrug resistance mechanisms. Thus, gene therapy has been a potential therapeutic approach owing to its ability to introduce, silence, or change the content of the human genetic code for inhibiting tumor progression, angiogenesis, and metastasis. For the proper delivery of genes to tumor cells, it requires the use of gene vectors for protecting the therapeutic gene and transporting it into cells. Among these vectors, liposomes have been the nonviral vector most used because of their low immunogenicity and low toxicity. Furthermore, this nanosystem can have its surface modified with ligands (e.g., antibodies, peptides, aptamers, folic acid, carbohydrates, and others) that can be recognized with high specificity and affinity by receptor overexpressed in tumor cells, increasing the selective delivery of genes to tumors. In this context, the present review address and discuss the main targeting ligands used to functionalize liposomes for improving gene delivery with potential application in cancer treatment.

23 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MLMarcela Tavares Luiz
Marcela Tavares Luiz
JDJessyca Aparecida Paes Dutra
Jessyca Aparecida Paes Dutra
JVJuliana S Rosa Viegas
Juliana S Rosa Viegas
JAJennifer Thayanne Cavalcante de Araújo
Jennifer Thayanne Cavalcante de Araújo
Alberto Tavares JuniorAlberto Tavares Junior
Alberto Tavares Junior
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Cancer is one of the major public health problems worldwide. Despite the advances in cancer therapy, it remains a challenge due to the low specificity of treatment and the development of multidrug resistance mechanisms. To overcome these drawbacks, several drug delivery nanosystems have been investigated, among them, magnetic nanoparticles (MNP), especially superparamagnetic iron oxide nanoparticles (SPION), which have been applied for treating cancer. MNPs have the ability to be guided to the tumor microenvironment through an external applied magnetic field. Furthermore, in the presence of an alternating magnetic field (AMF) this nanocarrier can transform electromagnetic energy in heat (above 42 °C) through Néel and Brown relaxation, which makes it applicable for hyperthermia treatment. However, the low chemical and physical stability of MNPs makes their coating necessary. Thus, lipid-based nanoparticles, especially liposomes, have been used to encapsulate MNPs to improve their stability and enable their use as a cancer treatment. This review addresses the main features that make MNPs applicable for treating cancer and the most recent research in the nanomedicine field using hybrid magnetic lipid-based nanoparticles for this purpose.

24 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MLMarcela Tavares Luiz
Marcela Tavares Luiz
LFLeonardo Delello Di Filippo
Leonardo Delello Di Filippo
JDJessyca Aparecida Paes Dutra
Jessyca Aparecida Paes Dutra
JVJuliana S Rosa Viegas
Juliana S Rosa Viegas
ASAmanda Letícia Polli Silvestre
Amanda Letícia Polli Silvestre
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Dental caries is the most common oral disease, with high prevalence rates in adolescents and low-income and lower-middle-income countries. This disease originates from acid production by bacteria, leading to demineralization of the dental enamel and the formation of cavities. The treatment of caries remains a global challenge and the development of effective drug delivery systems is a potential strategy. In this context, different drug delivery systems have been investigated to remove oral biofilms and remineralize dental enamel. For a successful application of these systems, it is necessary that they remain adhered to the surfaces of the teeth to allow enough time for the removal of biofilms and enamel remineralization, thus, the use of mucoadhesive systems is highly encouraged. Among the systems used for this purpose, liquid crystalline systems, polymer-based nanoparticles, lipid-based nanoparticles, and inorganic nanoparticles have demonstrated great potential for preventing and treating dental caries through their own antimicrobial and remineralization properties or through delivering drugs. Therefore, the present review addresses the main drug delivery systems investigated in the treatment and prevention of dental caries.